Date of Application Deadline: January 13, 2023
The Making More Health Business Accelerator is a structured program for business expansion aimed at social entrepreneurs with novel health sector solutions. The program provides two stages of participation.
The “Pilot Phase,” which lasts for a year, is where entrepreneurs are supported to:
Determine strategic possibilities and/or difficulties for their social enterprises’ expansion, sustainability, and impact.
b) jointly develop and test pertinent solutions.
Phase 2, dubbed the “Scale-up Phase,” likewise lasts 12 months and is dedicated to assisting participants in scaling up effective solutions from the engagement’s initial phase. Participants in both phases are given access to technical assistance from Boehringer Ingelheim staff members, strategic networks, financial resources, and a forum for interaction with other social entrepreneurs and ecosystem actors.
The accelerator’s main objective is to encourage social entrepreneurs who have creative ideas for improving healthcare access in Sub-Saharan Africa. Both the human and animal health fields may hold the answers. At this time, we are specifically choosing individuals from Kenya, Uganda, Rwanda, Nigeria, and Ghana.
If you have an original idea for improving human or animal health that fits the above description and you complete the requirements below, you should apply for the program.
Legal Entity: Limited Liability Company, Non-Governmental Organization
Age: Has been in use for at least three years.
Sector: Concerns with human or animal health.
Ghana, Nigeria, Kenya, Uganda, and Rwanda comprise the operating nations.
Revenue: Annual sales revenue of at least $100,000 USD.
Social impact evidence with precisely specified impact measurements
The program gives participants several chances to advance professionally and build their business endeavors. includes live and recorded workshops and seminars on a variety of themes, such as social finance, system change, replication, and operations.
Participants get access to skilled Boehringer Ingelheim staff members who provide their time voluntarily to offer practical technical support across a range of professional fields. Through an Executive in Residence program, which places seasoned executives within the social entrepreneurs’ organizations for between 2-4 weeks to concentrate on particular areas of the projects, engagement with BI staff members may take place digitally or in person.
Participants in the accelerator become a part of an ecosystem of ecosystem actors—impact investors, foundations, philanthropists, government organizations, corporate executives, social entrepreneurs, experts, and multinational healthcare companies—that is constantly expanding and tightly knit and dedicated to enhancing access to healthcare for people and animals in Africa.
Support for Financial and Investor Access
Each participant in the initiative receives a grant of €50,000 to be used for pilot implementation, with the prospect of additional scale-up funding after a successful trial. In order to facilitate access to outside investors, participants also receive expert-led investment preparedness coaching and support before and after the program.
Boehringer Ingelheim and an accelerator participant may develop a strategic business partnership where there is a timing and strategic match, with the promise of considerable long-term advantages for both parties.
Applications must be submitted between 14 November 2022 and 13 January 2023.
between January 14 and February 20, 2023
site visit and diligence
February 1, 2023, until February 28, 2023
March 15, 2023
Announcement of those that were chosen.
March 17, 2023